This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: University of California. Active years: 2019-2021.
Company Filing History:
Years Active: 2019-2021
Title: Innovations of Ching-Hsien Chen
Introduction
Ching-Hsien Chen is a notable inventor based in Davis, CA (US). He has made significant contributions to the field of medical research, particularly in the area of allergic lung inflammation and hyperreactivity. With a total of 3 patents, his work has the potential to impact the treatment of various diseases.
Latest Patents
One of his latest patents focuses on the suppression of allergic lung inflammation and hyperreactivity. This disclosure relates to compositions of isolated polypeptides and methods of their use for the treatment and prevention of disease or disease symptoms associated with MARCKS phosphorylation and/or dissociation from the cell membrane. The conditions addressed include allergic inflammation, asthma, chronic bronchitis, COPD, infection, hyper-reactivity, cystic fibrosis, ulcerative colitis, Crohn's disease, irritable bowel syndrome, rosacea, eczema, psoriasis, acne, arthritis, rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.
Career Highlights
Ching-Hsien Chen is affiliated with the University of California, where he conducts his research and develops his innovative solutions. His work is characterized by a strong focus on addressing complex health issues through scientific advancements.
Collaborations
Ching-Hsien Chen collaborates with several talented individuals in his field, including Reen Wu and Chen-Chen Lee. Their combined expertise contributes to the success of their research initiatives.
Conclusion
Ching-Hsien Chen's contributions to medical research through his patents demonstrate his commitment to improving health outcomes. His innovative approaches to treating allergic lung inflammation and related conditions highlight the importance of ongoing research in this critical area.